Cargando…

Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma

Immune checkpoint inhibitors have limited efficacy in the treatment of pancreatic ductal adenocarcinoma (PDAC). We investigated prognostic markers for nivolumab-based therapy in advanced or recurrent PDAC. Consecutive patients receiving nivolumab-based therapy at our institution between 2015 and 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shih-Hung, Lu, Li-Chun, Kao, Hsiang-Fong, Chen, Bang-Bin, Kuo, Ting-Chun, Kuo, Sung-Hsin, Tien, Yu-Wen, Bai, Li-Yuan, Cheng, Ann-Lii, Yeh, Kun-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477954/ https://www.ncbi.nlm.nih.gov/pubmed/34595057 http://dx.doi.org/10.1080/2162402X.2021.1973710

Ejemplares similares

Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
por: Yang, Shih-Hung, et al.
Publicado: (2022)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
por: Yang, Shih-Hung, et al.
Publicado: (2017)

Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report
por: Peng, Shang-Hsuan, et al.
Publicado: (2022)

Applying Machine Learning to Carotid Sonographic Features for Recurrent Stroke in Patients With Acute Stroke
por: Lin, Shih-Yi, et al.
Publicado: (2022)

Radiotherapy for hypersplenism from congestive splenomegaly
por: Liu, Mu-Tai, et al.
Publicado: (2004)

Splenectomy for Splenomegaly
por: Nixon, J. A.
Publicado: (1913)

Splenomegaly in Britain
por: McNee, J. W.
Publicado: (1929)

Splenomegaly in Britain
por: McNee, J. W.
Publicado: (1929)

Lymphadenopathy and Splenomegaly
por: Lanzkowsky, Philip
Publicado: (2011)

Splenectomy for Splenomegaly
Publicado: (1914)

Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience
por: Kao, Ming-Wei, et al.
Publicado: (2023)

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden
por: Kang, Nai-Wen, et al.
Publicado: (2021)

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2019)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

An Uncommon Cause of Splenomegaly
por: Dey, Biswajit, et al.
Publicado: (2016)

Splenectomy for Tropical Splenomegaly
Publicado: (1935)

Splenectomy for Tropical Splenomegaly
por: Palit, A. N.
Publicado: (1935)

Surgery for massive splenomegaly
por: Lemaire, J., et al.
Publicado: (2017)

Notes on Splenomegaly and Splenectomy
por: McKendrick, J. Souttar
Publicado: (1922)

Management of massive splenomegaly
por: Hudson, Victoria E., et al.
Publicado: (2021)

Splenomegaly in Children and Adolescents
por: Suttorp, Meinolf, et al.
Publicado: (2021)

Trichobezoar masquerading as massive splenomegaly: Rapunzel's syndrome revisited
por: Koh, Alex Zhi Yang, et al.
Publicado: (2022)

Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022)

5-Fluorouracil-related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply
por: Yeh, Kun-Huei, et al.
Publicado: (1998)

Fever, splenomegaly and lymphopenia in sarcoidosis
por: Ravaglia, Claudia, et al.
Publicado: (2013)

Pedunculine. (For Treatment of Bengal Splenomegaly)
por: Sanyal, Subodh Chandra
Publicado: (1946)

The Treatment of Splenomegaly with Anæmia in Syphilitics
por: Eason, J.
Publicado: (1918)

Abdominal Fibroma Simulating Splenomegaly
por: Alexander, David A.
Publicado: (1908)

The Treatment of Splenomegaly by Injections of Milk
por: Pasricha, C. L., et al.
Publicado: (1938)

Lymphomatoid Granulomatosis with Splenomegaly and Pancytopenia
por: HALVANI, Abolhasan, et al.
Publicado: (2010)

Splenomegaly and Pancytopenia in an Elderly Male
por: Aldossary, Nada J., et al.
Publicado: (2019)

Dwarfism associated with wandering splenomegaly
por: Petroianu, Andy, et al.
Publicado: (2022)

Outcome of pregnancy in women with splenomegaly
por: Ali, AbdelAziem A., et al.
Publicado: (2023)

Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma
por: Kuo, Kung-Kai, et al.
Publicado: (2016)

Machine Learning and Radiomics of Bone Scintigraphy: Their Role in Predicting Recurrence of Localized or Locally Advanced Prostate Cancer
por: Wang, Yu-De, et al.
Publicado: (2023)

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma
por: Costa, Rubens Barros, et al.
Publicado: (2018)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells
por: Chiu, Ching-Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9eif8646f7avbkqbcc865s9alj